2 documents found, page 1 of 1
Risperidone-ISM® effectiveness and tolerability in acute schizophrenia patients...
Correll, Christoph U.; Rohner, Henrik; Dimalta, Savino; Göldner, Randi Susanne; Assion, Hans Jörg; Langner-Timm, Steffi; Núñez Sande, CarmenObjective: To evaluate the effectiveness, time to discharge, functioning, and tolerability of Risperidone-ISM® in hospitalised patients with schizophrenia relapse. Methods: Non-interventional, multicentre, prospective study of adults admitted for acute exacerbation of schizophrenia and treated with Risperidone-ISM®. Effectiveness was assessed using the Clinical Global Impression-Severity scale (CGI-S) and 6-ite...
Managing schizophrenia with affective, sexual, metabolic and substance-use como...
Vieta, Eduard; Montejo, Ángel L.; Pillinger, Toby; Dell’Osso, Bernardo M.; Dimitraka, Maria; Farooq, Saeed; Jesus, Gustavo; Torres, Carlos ParroBackground: Schizophrenia is a complex psychiatric disorder frequently complicated by comorbidities that contribute to functional impairment, poor treatment adherence, and elevated mortality. Among the most prevalent and burdensome are affective symptoms, sexual dysfunction, metabolic disturbances, and substance use disorders, which remain underrecognized and insufficiently addressed in routine care. Objectives...